Pilar A. Saiz, PhD

  • 3Articles
  • 11.5KReads
  • 2002–2022Active
  • 17Collaborators
  • 15Citations

About

Pilar A. Saiz, PhD, is affiliated with the Department of Psychiatry at Universidad de Oviedo and several research institutes in Oviedo, Spain, including CIBERSAM and INEUROPA. Saiz has published on topics related to COVID-19, schizophrenia and schizoaffective disorders, and suicide, with studies examining suicidal ideation trends during the COVID-19 pandemic and the tolerability of high-dose quetiapine monotherapy. The author’s work spans from 2002 to 2022 and includes collaborations with Julio Bobes, Maria P. Garcia-Portilla, and others.

Publications

JCP
Suicidal Ideation and Associated Factors in Spain During the First Year of COVID-19
Brief Report

Suicidal Ideation and Associated Factors in Spain During the First Year of COVID-19

March 7, 2022

This study reports the prevalence of active and passive suicidal ideation in the general population of Spain at 3 timepoints during the COVID-19 pandemic.
, , , et al
JCP
Brief Report

Passive Suicidal Ideation in the Early Stage of the COVID-19 Pandemic and Lockdown in a Spanish Sample

October 6, 2020

This study draws on an online survey conducted to determine the prevalence of passive suicidal ideation early in the COVID-19 pandemic in Spain. Read the report to learn about...
, , , et al
JCP
Letter to the Editor

High Degree of Tolerability for Monotherapy With High Doses of Quetiapine: A Case Report

November 1, 2002

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe